Your premiere sourcing site for Biopharma and Bioprocess. #upstream #downstream #chromatography #logistics #quality #filtration #singleuse
Erie, PA
Joined June 2009
- Tweets15K
- Following1.1K
- Followers2.9K
- Likes58
Bioprocess Online retweeted
RT @BioProcessOL Part 1 of this two-part series compared environmental impact of biopharma continuous manufacturing with batch manufacturing. In article, we consider process efficiency, single-use technology, and facilities requirements. bioprocessonline.com/doc/wha… #biotech
Bioprocess Online retweeted
In article three of the #genesilencing series Giles Campion wrote for @BioProcessOL, he discusses the promise of gene silencing to treat not-so-rare diseases and even quite common diseases. READ it here: bit.ly/3QkUZPW #SilenceIsGOLDen
Bioprocess Online retweeted
Radek Spisek spoke with Matthew Pillar of @BioProcessOL about SOTIO’s Phase 2 basket study of our lead candidate, SOT101, as well as a potential inflection point in #ImmunoOncology. Learn more here: bit.ly/3eJp6Dm
Bioprocess Online retweeted
In this #BusinessOfBiotech (@BioProcessOL) #podcast, our CEO @Mahesh__Karande spoke with @mattpillar to discuss Omega’s work coopting nature’s universal operating system for #GeneControl in order to treat diseases with unmet need. Listen here: bit.ly/3BO7NtZ
Bioprocess Online retweeted
#ICYMI Our CEO James McArthur (and Georgia!) recently sat down with @mattpillar from @BioProcessOL to discuss PepGen's EDO technology and #neuromusculardisease programs for the #BusinessofBiotech podcast. Listen here: bit.ly/3aTp6z7
Bioprocess Online retweeted
Our CEO Lisa Deschamps has been profiled in the latest episode of the @BioProcessOL Business of Biotech podcast. Listen in to discover how AviadoBio is working to develop transformative gene therapies for #FTD: bioprocessonline.com/doc/gen…
Bioprocess Online retweeted
With more than 95% of rare diseases not having treatment options, the unmet is vast. In this @BioProcessOL article, Giles Campion wrote about #siRNA's and their potential for treating these rare diseases: bit.ly/3T0wcD6 #SilenceIsGOLDen
Bioprocess Online retweeted
Newer #antibody alternatives are supporting the rapid pace of #ADC development. Read the latest article from @BioProcessOL to find out how these next-generation #drugdelivery vehicles, such as #Optimer, are fine-tuning the future of ADCs. bioprocessonline.com/doc/adc…
Bioprocess Online retweeted
Editorial by @mattpillar, Editor at @BioProcessOL“Why It's Computational Biology's Time To Shine.” New #drug development platforms like Gain’s SEE-Tx® platform that improve the speed and efficiency of drug development are rapidly gaining awareness.$GANX
bioprocessonline.com/doc/why…
Bioprocess Online retweeted
#ICYMI: “The great promise of siRNA is its ability to hit targets that have long been considered “undruggable.” In this @BioProcessOL article, Silence's Giles Campion discusses the potential of #siRNA therapy to treat diseases: bit.ly/3oYHk5O #SilenceIsGOLDen
Bioprocess Online retweeted
Read as an expert considers the growing methylation analysis landscape in our latest publication on @ClinicalLeader1, @OutsourcedPharm , @BioProcessOL , @_CellandGene and @MedDeviceOnline .
clinicalleader.com/doc/the-m…
#methylation #biomarkers
Bioprocess Online retweeted
#ParkNews Listen to @arecor_plc CEO Sarah Howell discuss the company's approach to improving the quality of life for insulin-dependent patients on the @BioProcessOL #BusinessofBiotech podcast in partnership with @Cytiva
ow.ly/7j0n50JZSV2
Bioprocess Online retweeted
How do you produce #Antibodydrugconjugates that meet cGMP expectations? Click the link below to find out more! 👇
#ADC #Antibodydrugconjugate #Cancertreatment @BioProcessOL
bioprocessonline.com/doc/you…
Bioprocess Online retweeted
#BusinessOfBiotech #podcast is brought to you by @BioProcessOL in partnership with @Cytiva Check out this week’s episode featuring @PepGenTx CEO @cdnjamesg #Duchenne #musculardystrophy #DMD #genetherapy #oligonucleotides #musculardystrophy
bioprocessonline.com/doc/oli…
Bioprocess Online retweeted
Dr. Daniel Teper, co-founder and CEO of Cytovia Therapeutics, recently spoke with Matthew Pillar of @BioProcessOL about Cytovia’s dual iPSC-derived NK cell & NK engager antibody platforms for the treatment of #HCC.
Read the full article to learn more:
bit.ly/3z3d3bB
Bioprocess Online retweeted
#ICYMI Check out our CTO Gene Lee, Ph.D. chat with @mattpillar of @BioProcessOL on managing monoclonal #antibody risk on the panel ‘Overcoming Platform Inefficiencies in mAb Manufacturing’: bit.ly/3RSarVA
Bioprocess Online retweeted
Our CEO, Sarah Howell, featured on the #BusinessofBiotech podcast, where she discussed the use of our #Arestat™ platform to develop enhanced reformulations of therapeutics to transform #diabetes treatment. bioprocessonline.com/doc/cha…
#Arecor @mattpillar @BioProcessOL @Cytiva
Bioprocess Online retweeted
Dr. Daniel Teper, Co-Founder and CEO of Cytovia, spoke with @mattpillar, of @BioProcessOL, about @CytoviaTX’s induced pluripotent stem cell (IPSC)-derived NK cell and NK engager antibody platforms for treating #hepatocellularcarcinoma.
Learn more: bioprocessonline.com/doc/ips…
Bioprocess Online retweeted
Dr. Daniel Teper, co-founder and CEO of Cytovia Therapeutics, recently spoke with Matthew Pillar of @BioProcessOL about Cytovia’s dual iPSC-derived NK cell & NK engager antibody platforms for the treatment of #HCC.
Read the full article to learn more:
bit.ly/3z3d3bB